The effect of minocycline on Candida albicans.
Minocycline, a new tetracycline derivative, was found to inhibit the growth of Candida albicans. Inhibition was much affected by the composition of the medium and was difficult to demonstrate in fluid cultures. Study of the rate of budding in shallow broth cultures in Petri dishes showed that the addition of 20 mug/ml minocycline prolonged the lag phase by three hours. C. tropicalis was similarly inhibited and C. guilliermondii and C. parapsilosis to a lesser degree. Six other tetracyclines were tested and found to inhibit Candida only in very high concentrations.
D002175:Candida / Q000187:drug effects / Q000254:growth & development; D002176:Candida albicans / Q000187:drug effects* / Q000254:growth & development; D002751:Chlortetracycline / Q000494:pharmacology; D003470:Culture Media; D003707:Demeclocycline / Q000494:pharmacology; D004318:Doxycycline / Q000494:pharmacology; D005947:Glucose; D008690:Methacycline / Q000494:pharmacology; D008826:Microbial Sensitivity Tests; D008911:Minocycline / Q000494:pharmacology; D010118:Oxytetracycline / Q000494:pharmacology; D013395:Sucrose; D013752:Tetracycline / Q000494:pharmacology*
D003470:Culture Media; D013395:Sucrose; D003707:Demeclocycline; D013752:Tetracycline; D008911:Minocycline; D008690:Methacycline; D005947:Glucose; D004318:Doxycycline; D002751:Chlortetracycline; D010118:Oxytetracycline